Legend BiotechLEGN
那斯達克 · USD
18.90
+0.27
(+1.45%)
收盤 10/23 03:59 (UTC+8)
盤後
19.00
+0.10
(+0.53%)
10/23 03:59 (UTC+8)
Legend BiotechLEGN
18.90
+0.27
(+1.45%)
財務數據
損益表
- 0.94
- 1.87
- 1.60
- 1.87
- 1.95
- 2.55
- 2.72
- 3.06
- 3.05
- 3.88
- 18.28
- 98.45
- -14.11
- 16.43
- 4.55
- 30.82
- 6.75
- 12.50
- -0.42
- 27.01
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 387,500 | 305,100 | 306,377 | 272,330 | 255,100 | 195,000 | 186,522 | 160,205 | 186,523 | 93,991 |
營業成本 | 137,400 | 175,900 | 123,459 | 115,306 | 98,000 | 71,300 | 73,922 | 55,469 | 50,451 | 54,739 |
營業毛利 | 250,100 | 129,200 | 182,918 | 157,024 | 157,100 | 123,700 | 112,600 | 104,736 | 136,072 | 39,252 |
營業費用 | 192,400 | 179,000 | 203,520 | 200,476 | 179,000 | 175,400 | 186,995 | 175,092 | 178,042 | 157,116 |
研發費用 | 96,000 | 85,700 | 101,326 | 113,148 | 98,300 | 101,900 | 104,432 | 95,522 | 112,626 | 100,964 |
推銷及管理費用 | 96,400 | 90,100 | 101,194 | 87,328 | 80,700 | 72,500 | 83,126 | 79,570 | 65,416 | 56,152 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | 3,200 | - | - | - | 1,000 | -563 | -306 | -420 | -616 |
營業利益 | 57,700 | -49,800 | -20,602 | -43,452 | -21,900 | -51,700 | -74,395 | -70,356 | -41,970 | -117,864 |
其他收入及費用 | - | - | - | - | - | - | - | - | - | - |
利息費用 | 5,800 | 5,500 | 5,481 | 5,636 | 5,200 | 5,100 | 5,152 | 5,504 | 5,484 | 5,475 |
稅前純益 | 55,500 | -53,100 | -19,599 | -39,073 | -124,800 | -99,200 | 40,511 | -120,886 | -17,970 | -59,788 |
所得稅 | 22,300 | 1,200 | 11,216 | 616 | 600 | 1,800 | 14,227 | 4,435 | 226 | 5 |
稅後純益 | 33,200 | -54,300 | -30,815 | -39,689 | -125,400 | -101,000 | 26,284 | -125,321 | -18,196 | -59,793 |
基本每股稅後盈餘(元) | 0.18 | -0.30 | -0.16 | -0.22 | -0.68 | -0.54 | 0.14 | -0.68 | -0.10 | -0.32 |
稀釋每股稅後盈餘(元) | 0.18 | -0.30 | -0.16 | -0.22 | -0.68 | -0.54 | 0.14 | -0.68 | -0.10 | -0.32 |
基本平均股數(千股) | 187000.00 | 185100.00 | 184733.00 | 184636.00 | 184150.00 | 183750.00 | 183324.00 | 183281.00 | 182602.00 | 182005.00 |
稀釋平均股數(千股) | 193800.00 | 185100.00 | 184733.00 | 184636.00 | 184150.00 | 183750.00 | 201403.00 | 183281.00 | 182602.00 | 182005.00 |
還原基本每股稅後盈餘(元) | 0.18 | -0.30 | -0.16 | -0.22 | -0.68 | -0.54 | 0.14 | -0.68 | -0.10 | -0.32 |
還原稀釋每股稅後盈餘(元) | 0.18 | -0.30 | -0.16 | -0.22 | -0.68 | -0.54 | 0.14 | -0.68 | -0.10 | -0.32 |
還原基本平均股數(千股) | 187,000 | 185,100 | 184,733 | 184,636 | 184,150 | 183,750 | 183,324 | 183,281 | 182,602 | 182,005 |
還原稀釋平均股數(千股) | 193,800 | 185,100 | 184,733 | 184,636 | 184,150 | 183,750 | 201,403 | 183,281 | 182,602 | 182,005 |
EBITDA(千元) | 73,000 | -32,000 | -2,150 | -27,405 | -113,800 | -89,000 | 52,459 | -111,475 | -7,117 | -48,591 |